POMALIDOMIDE REIG JOFRE 4 mg, hard capsule 14 capsules
Active ingredients: Pomalidomide
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule14 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- POMALIDOMIDE REIG JOFRE 4 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 14 plaquettes prédécoupées unitairesPVC (ACLAR) polytrifluorochloroéthylène aluminium de 1 gélule
- Marketing authorisation holder
- LABORATORIO REIG JOFRE (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67099324CIP73031059CIP133400930310595Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POMALIDOMIDEgélule | 4 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.